Pliant Therapeutics Inc (PLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -160,572 | -102,809 | -46,955 | -161,336 | -120,227 |
| Depreciation Amortization | 3,612 | 2,079 | 1,604 | -3,149 | -8,838 |
| Accounts receivable | N/A | N/A | N/A | 1,983 | 1,983 |
| Accounts payable and accrued liabilities | 2,358 | -1,369 | 2,257 | 2,969 | 1,797 |
| Other Working Capital | 17,270 | 3,021 | 4,733 | 1,251 | 642 |
| Other Operating Activity | 29,491 | 23,510 | 8,090 | 41,921 | 33,384 |
| Operating Cash Flow | $-107,841 | $-75,568 | $-30,271 | $-116,361 | $-91,259 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 104,847 | 72,991 | 61,038 | -126,091 | -158,073 |
| PPE Investments | -3,639 | -2,743 | -1,492 | -921 | -860 |
| Investing Cash Flow | $101,208 | $70,248 | $59,546 | $-127,012 | $-158,933 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 19,909 | 19,909 | 19,909 | N/A | N/A |
| Common Stock Issued | 3,106 | 2,563 | 1,879 | 275,252 | 275,020 |
| Other Financing Activity | 0 | 0 | 0 | -847 | -834 |
| Financing Cash Flow | $23,015 | $22,472 | $21,788 | $274,405 | $274,186 |
| Beginning Cash Position | 64,716 | 64,716 | 64,716 | 33,684 | 33,685 |
| End Cash Position | 81,098 | 81,868 | 115,779 | 64,716 | 57,679 |
| Net Cash Flow | $16,382 | $17,152 | $51,063 | $31,032 | $23,994 |
| Free Cash Flow | |||||
| Operating Cash Flow | -107,841 | -75,568 | -30,271 | -116,361 | -91,259 |
| Capital Expenditure | -3,639 | -2,743 | -1,492 | -921 | -860 |
| Free Cash Flow | -111,480 | -78,311 | -31,763 | -117,282 | -92,119 |